Studies have demonstrated that T1D patients have lower bone resorption markers, such as C-terminal cross-linking telopeptide (CTX), and bone formation markers, such as osteocalcin (OCN), than healthy people. This evidence concerns the gene CYP27A1 and type 1 diabetes mellitus.